Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

General Electric Company (GE), Microsoft Corporation (MSFT): Blue Chips And Investment Trusts Among This Hedgie’s Top Picks

Page 1 of 2

Our report on the activity of hedge funds continues with the 13F filing of Redmond Asset Management, LLC, founded by Scott Redmond, its Chief Financial Analyst and Lead Portfolio Manager. The fund has made additions to their top holdings, which include blue chips like General Electric Company (NYSE:GE) and Microsoft Corporation (NASDAQ:MSFT). Let us analyze how the 5 biggest positions of Redmond have done in 2013 and where they stand now. Feel free to have a look at what other hedge funds are doing and also make sure to check out our premium offers.

It’s important to track hedge fund sentiment because it has been found that for investors who know where to look, it’s possible to beat the market by 18 percentage points a year. Learn more here.

Let’s get started

Redmond Asset Management added exactly 10,000 shares to their stake in MELA Sciences Inc (NASDAQ:MELA), its top holding. The company designs and develops instruments used to detect melanoma. The stock has continued its downtrend that started in 2010 and has fallen 41% since the start of 2013.The financial results for the first quarter of 2013 show that it was the company’s best quarter in terms of revenue, yet it continues to bleed money, with Earnings Per Share (EPS) of $-0.17. A beta of -0.17 can explain the slide of the stock, in contrast to the slow recovery of the market after the credit crunch. Perhaps Redmond considers the stock to be at a turning point and expects it to turn profits soon.

General Electric Company (NYSE:GE)

The second largest position of Redmond Asset Management is General Electric Company (NYSE:GE). The stock of the US giant has started an up-trend in January and reached a 2013 high of $23.9 on March 8. The correction ended on April 22 and the stock price has been growing ever since. General Electric Company (NYSE:GE)’s stock is traded at a trailing Price to Earnings (PE) ratio of 16.80, while the forward P/E ratio is 12.46. This is a sign the market expects the company to increase its revenues and earnings. Eight of the 17 analysts monitoring the stock recommend it as a Buy and 4 of them rate it as a Strong Buy. They also expect earnings to continue growing in 2013 and 2014 and have set a price range of $22-$28 .

With a small addition of 300 shares, Monmouth Real Estate Investment Corp. (NYSE:MNR) occupies the third place among Redmond’s biggest positions. On April 9, Monmouth R.E. Inv. Corp. (NYSE:MNR) announced the introduction of a dividend of $0.15 per share payable June 17, 2013. The stock has a beta of 0.65 and a Levered Free Cash Flow of $18 million. Only one of three analysts recommend the stock as a buy. Although they expect the revenue to grow in 2014, they believe the EPS to decrease slightly. The investment trust is traded at a trailing P/E ratio of 35.15 while the forward P/E is 53.25.

Another position to with Scott Redmond added since the start of 2013 is Microsoft Corporation (NASDAQ:MSFT). With Windows 8 failing to win the hearts of PC users, Microsoft Corporation (NASDAQ:MSFT)’s hopes lie in a new game console, the Xbox 720, which is expected to be released by the end of 2013. Furthermore, Microsoft has stepped up their efforts to gain more of the smartphone market share by helping their partners – Nokia Corporation (ADR) (NYSE:NOK) – to promote the new, cheaper Lumia 521. Microsoft pays a dividend of $0.86 and has a beta of 1.18, which puts it among reasonably safe bets. Eighteen of the 38 analysts monitoring the stock recommend it as a Buy or Strong Buy and have set a price range of $27-$39.

The best of the rest

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!